Applicant, as named in the Orange Book

Reckitt Benckiser

Next listed expiry: Mucinex 12hr Cold & Fever Multi-Symptom on 11 Oct 2036. 1 products with live protection, 4 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Mucinex 12hr Cold & Fever Multi-Symptom dextromethorphan hydrobromide; guaifenesin; naproxen sodium	dextromethorphan hydrobromide; guaifenesin; naproxen sodium	217338	11 Oct 2036	patent

Recent events

Delsym · Generic approved · ANDA 218417, Aurobindo Pharma LtdApproved 15 Apr 2026Detected 25 Oct 2026

Products without listed protection (4)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Delsym dextromethorphan polistirex	dextromethorphan polistirex	018658	open now	no listed protection
Mucinex · 2 strengths guaifenesin	guaifenesin	021282	open now	no listed protection
Mucinex D · 2 strengths guaifenesin; pseudoephedrine hydrochloride	guaifenesin; pseudoephedrine hydrochloride	021585	open now	no listed protection
Mucinex Dm · 2 strengths dextromethorphan hydrobromide; guaifenesin	dextromethorphan hydrobromide; guaifenesin	021620	open now	no listed protection